Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX for Treatment of Vestibular Migraine
KCT0006974Phase 4Completed
- Sponsor
- Ministry of Science and ICT
- Start
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in vestibular migraine (VM), migraine, sponsored by Ministry of Science and ICT. Started Nov 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
vestibular migraine (VM)migraine
Beyond the preview
Go deeper on KCT0006974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006974.